Mark Foley

(Mr. Mark Foley)

Hält derzeit Positionen bei Revance Therapeutics Inc, SI-BONE Inc, ZELTIQ Aesthetics Inc and Revance Therapeutics Inc

Position

Position Company Period
Independent Director Revance Therapeutics Inc 5. September 2017 -
Independent Director SI-BONE Inc 17. Juni 2019 -
President, Chief Executive Officer ZELTIQ Aesthetics Inc 28. April 2017 -
President, Chief Executive Officer, Director Revance Therapeutics Inc 13. Oktober 2019 -
Independent Director Revance Therapeutics Inc 5. September 2017 - 13. Oktober 2019
Chairman of the Board, President, Chief Executive Officer ZELTIQ Aesthetics Inc 1. Januar 2015 - 28. April 2017
President, Chief Executive Officer, Director ZELTIQ Aesthetics Inc 19. November 2012 - 1. Januar 2015
President, Chief Executive Officer, Interim Chief Financial Officer, Director ZELTIQ Aesthetics Inc 23. August 2012 - 19. November 2012
Interim President, Chief Executive Officer, Interim Chief Financial Officer, Director ZELTIQ Aesthetics Inc 9. August 2012 - 23. August 2012
Interim President and Chief Executive Officer, Director ZELTIQ Aesthetics Inc 19. April 2012 - 9. August 2012
Director ZELTIQ Aesthetics Inc 1. Mai 2010 - 19. April 2012
Mark Foley's trades of Glaukos Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Kauf • Verkauf • Geplanter Kauf • Geplanter Verkauf Netto-Kauf Netto-Verkauf Earnings
Abkürzungen K: Kauf, V: Verkauf, GK: Geplanter Kauf, GV: Geplanter Verkauf, S: Sonstiges
Datum der Benachrichtigung Datum der Transaktion K/V Art der Transaktion Anz. der Aktien
Kurs
Wert 		Anzahl der Aktien Kurs Wert Details
2025-02-28 2025-02-26
US Glaukos Corp (GKOS)
V Verkauf
20.687 -27.6%
120,72
2.497.335 USD 		20.687 -27.6% 120,72 2.497.335 USD
2024-03-08 2024-03-06
K Kauf
30.000 +3.0%
6,98
209.400 USD 		30.000 +3.0% 6,98 209.400 USD
2024-02-26 2024-02-23
US Glaukos Corp (GKOS)
V Verkauf
4.560 -12.1%
92,87
423.487 USD 		4.560 -12.1% 92,87 423.487 USD
2023-08-04 2023-08-03
GV Geplanter Verkauf
26.279 -3.0%
22,57
593.151 USD 		26.279 -3.0% 22,57 593.151 USD
2023-07-05 2023-07-03
GV Geplanter Verkauf
26.279 -2.9%
24,94
655.333 USD 		26.279 -2.9% 24,94 655.333 USD
2023-06-13 2023-06-09
GV Geplanter Verkauf
31.279 -3.4%
30,72
960.928 USD 		31.279 -3.4% 30,72 960.928 USD
2023-05-16 2023-05-15
V Verkauf
70.447 -7.1%
34,55
2.433.725 USD 		70.447 -7.1% 34,55 2.433.725 USD
2023-03-09 2023-03-09
V Verkauf
70.390 -7.9%
31,59
2.223.360 USD 		70.390 -7.9% 31,59 2.223.360 USD
2021-11-29 2021-11-29
K Kauf
40.000 +56.4%
12,90
515.924 USD 		40.000 +56.4% 12,90 515.924 USD
2016-03-23 2016-03-22
GV Geplanter Verkauf
9.698 -2.6%
25,01
242.568 USD 		9.698 -2.6% 25,01 242.568 USD
2016-03-22 2016-03-18
GV Geplanter Verkauf
1.272 -0.3%
25,01
31.816 USD 		1.272 -0.3% 25,01 31.816 USD
// ... existing code ... // ... rest of the file ...